Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D
In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy and followed for 15 years to see which was the best option. Have a listen and hear what was found. Show Notes 1) Fifteen-Year Outcomes…
BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D








Please provide any additional comments (optional).